Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1962 1
1973 1
1974 4
1975 1
1976 1
1977 4
1978 2
1980 2
1985 1
1987 1
1989 2
1990 4
1991 3
1992 1
1993 3
1994 2
1995 2
1996 4
1997 4
1998 2
1999 2
2000 3
2001 2
2002 2
2003 3
2004 1
2005 10
2006 8
2007 2
2008 4
2009 4
2010 4
2011 7
2012 6
2013 10
2014 6
2015 10
2016 6
2017 9
2018 7
2019 9
2020 8
2021 12
2022 14
2023 13
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

198 results

Results by year

Filters applied: . Clear all
Page 1
A new age of precision gene therapy.
Schambach A, Buchholz CJ, Torres-Ruiz R, Cichutek K, Morgan M, Trapani I, Büning H. Schambach A, et al. Among authors: buchholz cj. Lancet. 2024 Feb 10;403(10426):568-582. doi: 10.1016/S0140-6736(23)01952-9. Epub 2023 Nov 22. Lancet. 2024. PMID: 38006899 Review.
In Vivo Generation of CAR T Cells Selectively in Human CD4+ Lymphocytes.
Agarwal S, Hanauer JDS, Frank AM, Riechert V, Thalheimer FB, Buchholz CJ. Agarwal S, et al. Among authors: buchholz cj. Mol Ther. 2020 Aug 5;28(8):1783-1794. doi: 10.1016/j.ymthe.2020.05.005. Epub 2020 May 16. Mol Ther. 2020. PMID: 32485137 Free PMC article.
AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma.
Strecker MI, Wlotzka K, Strassheimer F, Roller B, Ludmirski G, König S, Röder J, Opitz C, Alekseeva T, Reul J, Sevenich L, Tonn T, Wels WS, Steinbach JP, Buchholz CJ, Burger MC. Strecker MI, et al. Among authors: buchholz cj. Oncoimmunology. 2022 Oct 11;11(1):2127508. doi: 10.1080/2162402X.2022.2127508. eCollection 2022. Oncoimmunology. 2022. PMID: 36249274 Free PMC article.
AAV vectors displaying bispecific DARPins enable dual-control targeted gene delivery.
Theuerkauf SA, Herrera-Carrillo E, John F, Zinser LJ, Molina MA, Riechert V, Thalheimer FB, Börner K, Grimm D, Chlanda P, Berkhout B, Buchholz CJ. Theuerkauf SA, et al. Among authors: buchholz cj. Biomaterials. 2023 Dec;303:122399. doi: 10.1016/j.biomaterials.2023.122399. Epub 2023 Nov 16. Biomaterials. 2023. PMID: 37992599 Free article.
Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside?
Guedan S, Luu M, Ammar D, Barbao P, Bonini C, Bousso P, Buchholz CJ, Casucci M, De Angelis B, Donnadieu E, Espie D, Greco B, Groen R, Huppa JB, Kantari-Mimoun C, Laugel B, Mantock M, Markman JL, Morris E, Quintarelli C, Rade M, Reiche K, Rodriguez-Garcia A, Rodriguez-Madoz JR, Ruggiero E, Themeli M, Hudecek M, Marchiq I. Guedan S, et al. Among authors: buchholz cj. J Immunother Cancer. 2022 May;10(5):e003487. doi: 10.1136/jitc-2021-003487. J Immunother Cancer. 2022. PMID: 35577501 Free PMC article. Review.
APPsα Rescues Tau-Induced Synaptic Pathology.
Bold CS, Baltissen D, Ludewig S, Back MK, Just J, Kilian L, Erdinger S, Banicevic M, Rehra L, Almouhanna F, Nigri M, Wolfer DP, Spilger R, Rohr K, Kann O, Buchholz CJ, von Engelhardt J, Korte M, Müller UC. Bold CS, et al. Among authors: buchholz cj. J Neurosci. 2022 Jul 20;42(29):5782-5802. doi: 10.1523/JNEUROSCI.2200-21.2022. Epub 2022 Jun 6. J Neurosci. 2022. PMID: 35667850 Free PMC article.
198 results